Association of blood active matrix metalloproteinase-3 with carotid plaque score from a community population in Taiwan

Atherosclerosis

Volumn 212, Issue 2, 2010, Pages 595-600

  Lien, Li Ming ^a,b,c   Hsieh, Yi Chen ^d   Bai, Chyi Huey ^d   Chen, Wei Hung ^b,c   Chiu, Hou Chang ^c,e   Hsieh, Fang I ^d   Shyu, Kou Gi ^a,c   Chiou, Hung Yi ^d   Hsu, Chung Y ^f  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Blood active matrix metalloproteinase 3; Carotid plaque; MMP 3 genotype

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; STROMELYSIN;

ADULT; AGED; ARTICLE; B SCAN; CAROTID ATHEROSCLEROSIS; COMMUNITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCORING SYSTEM; TAIWAN;

AGED; ATHEROSCLEROSIS; CAROTID ARTERIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROMOTER REGIONS, GENETIC; REGRESSION ANALYSIS; TAIWAN; TUNICA INTIMA; TUNICA MEDIA;

EID: 77957717390     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.05.040     Document Type: Article

References (30)

1. O'Leary D.H., Polak J.F., Kronmal R.A., et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999, 340:14-22.
2. Crouse J.R., Harpold G.H., Kahl F.R., Toole J.F., McKinney W.M. Evaluation of a scoring system for extracranial carotid atherosclerosis extent with B-mode ultrasound. Stroke 1986, 17:270-275.
3. Sutton-Tyrrell K., Wolfson S.K., Thompson T., Kelsey S.F. Measurement variability in duplex scan assessment of carotid atherosclerosis. Stroke 1992, 23:215-220.
4. Su T.C., Jeng J.S., Chien K.L., et al. Hypertension status is the major determinant of carotid atherosclerosis: a community-based study in Taiwan. Stroke 2001, 32:2265-2271.
5. Spence J.D. Measurement of intima-media thickness vs. carotid plaque: uses in patient care, genetic research and evaluation of new therapies. Int J Stroke 2006, 1:216-221.
6. Blackburn R., Giral P., Bruckert E., et al. Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterioscler Thromb Vasc Biol 2001, 21:1962-1968.
7. Koenig W., Khuseyinova N. Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 2007, 27:15-26.
8. Beaudeux J.L., Giral P., Bruckert E., et al. Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia. Atherosclerosis 2003, 169:139-146.
9. Orbe J., Fernandez L., Rodriguez J.A., et al. Different expression of MMPs/TIMP-1 in human atherosclerotic lesions. Relation to plaque features and vascular bed. Atherosclerosis 2003, 170:269-276.
10. Henney A.M., Wakeley P.R., Davies M.J., et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 1991, 88:8154-8158.
11. Ghilardi G., Biondi M.L., DeMonti M., et al. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 2002, 33:2408-2412.
12. Rauramaa R., Vaisanen S.B., Luong L.A., et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 2000, 20:2657-2662.
13. Olson F.J., Schmidt C., Gummesson A., et al. Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis. J Intern Med 2008, 263:626-635.
14. Romero J.R., Vasan R.S., Beiser A.S., et al. Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the Framingham Offspring Study. J Stroke Cerebrovasc Dis 2008, 17:412-417.
15. Hsieh Y.C., Hung C.T., Lien L.M., et al. A significant decrease in blood pressure through a family-based nutrition health education programme among community residents in Taiwan. Public Health Nutr 2009, 12:570-577.
16. Touboul P.J., Hennerici M.G., Meairs S., et al. Mannheim carotid intima-media thickness consensus (2004-2006). Cerebrovasc Dis 2007, 23:75-80.
17. Lim T.K., Lim E., Dwivedi G., Kooner J., Senior R. Normal value of carotid intima-media thickness - a surrogate marker of atherosclerosis: quantitative assessment by B-mode carotid ultrasound. J Am Soc Echocardiogr 2008, 21:112-116.
18. Fang S., Jin X., Wang R., et al. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis 2005, 26:481-486.
19. Zhou X., Huang J., Chen J., et al. Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population. The Beijing atherosclerosis study. Thromb Haemost 2004, 92:867-873.
20. Jones G.T., Phillips V.L., Harris E.L., et al. Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm. J Vasc Surg 2003, 38:1363-1367.
21. Sundstrom J., Vasan R.S. Circulating biomarkers of extracellular matrix remodeling and risk of atherosclerotic events. Curr Opin Lipidol 2006, 17:45-53.
22. Wu Y.W., Yang W.S., Chen M.F., et al. High serum level of matrix metalloproteinase-1 and its rapid surge after intervention in patients with significant carotid atherosclerosis. J Formos Med Assoc 2008, 107:93-98.
23. Samnegard A., Silveira A., Tornvall P., et al. Lower serum concentration of matrix metalloproteinase-3 in the acute stage of myocardial infarction. J Intern Med 2006, 259:530-536.
24. Ye S., Eriksson P., Hamsten A., et al. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996, 271:13055-13060.
25. Zhu C., Odeberg J., Hamsten A., et al. Allele-specific MMP-3 transcription under in vivo conditions. Biochem Biophys Res Commun 2006, 348:1150-1156.
26. Rundek T., Elkind M.S., Pittman J., et al. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke 2002, 33:1420-1423.
27. Djuric T., Zivkovic M., Radak D., et al. Association of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosis. Clin Biochem 2008, 41:1326-1329.
28. Terashima M., Akita H., Kanazawa K., et al. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction. Circulation 1999, 99:2717-2719.
29. Ye S. Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 2006, 69:636-645.
30. Mattey D.L., Nixon N.B., Dawes P.T., et al. Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis. Genes Immun 2004, 5:147-149.